A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease


The main purpose of the study is to evaluate the efficacy and safety of the study drug known as prasugrel for the reduction of Vaso-Occlusive Crisis events in pediatric participants with sickle cell disease. The study will also investigate reduction in daily pain in children who have sickle cell disease.


More information: clinicaltrials.gov, ITHANET Clinical Trials